vimarsana.com

Latest Breaking News On - Tergene biotech - Page 1 : vimarsana.com

Aurobindo Pharma JV gets SEC recommendation for pneumococcal 15 valent (PCV15) vaccine

Business News | Govt Expert Panel Recommends JV Firm's Vaccine for Pneumococcal Infections

Get latest articles and stories on Business at LatestLY. PCV15 vaccine was developed by Tergene Biotech and manufactured at Auro Vaccines, which is a wholly-owned subsidiary of Aurobindo Pharma with capabilities in vaccines development and manufacturing. Aurobindo Pharma holds 80 per cent stake in the joint venture company, Tergene Biotech. Business News | Govt Expert Panel Recommends JV Firm s Vaccine for Pneumococcal Infections.

Tergene Biotech gets recommendation from CDSCO subject expert committee for pneumococcal 15-valent vaccine

Stocks To Watch: GMR Infra, Future Retail, RBL Bank, Aurobindo Pharma, Adani Enterprises

Hyderabad, the new vaccine capital of India

Hyderabad, the new vaccine capital of India Apart from Covaxin and Sputnik V, companies based in the city are also involved in developing or manufacturing several other Covid-19 vaccines. Jan 23, 2021 When a senior technical team from Russia’s health ministry descended on Hyderabad in November 2020, nobody knew that it was breaking an emerging oligopoly in the Indian market, quietly but decisively. The manufacturing of the Covid-19 vaccine wasn’t meant to be restricted to a few. After auditing several facilities across the country, the Russian team chose three companies from Hyderabad, to undertake clinical trials for its Covid-19 vaccine, Sputnik V, in India and contract-manufacture the vaccine Dr Reddy’s Laboratories (DRL), Hetero Biopharma, and Virchow Biotech.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.